Tower Research Capital (TRC)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-33,086
| Closed | -$1.35M | – | 6116 |
|
|
2024
Q2 | $1.35M | Buy |
33,086
+32,358
| +4,445% | +$1.32M | 0.02% | 579 |
|
|
2024
Q1 | $30.8K | Sell |
728
-4,753
| -87% | -$201K | ﹤0.01% | 2634 |
|
|
2023
Q4 | $232K | Buy |
5,481
+4,084
| +292% | +$173K | ﹤0.01% | 1973 |
|
|
2023
Q3 | $30.5K | Sell |
1,397
-2,865
| -67% | -$62.5K | ﹤0.01% | 3008 |
|
|
2023
Q2 | $135K | Buy |
4,262
+1,588
| +59% | +$50.5K | ﹤0.01% | 1823 |
|
|
2023
Q1 | $65K | Sell |
2,674
-1,073
| -29% | -$26.1K | ﹤0.01% | 2274 |
|
|
2022
Q4 | $118K | Sell |
3,747
-902
| -19% | -$28.4K | ﹤0.01% | 1707 |
|
|
2022
Q3 | $131K | Sell |
4,649
-1,435
| -24% | -$40.4K | ﹤0.01% | 2317 |
|
|
2022
Q2 | $161K | Buy |
6,084
+578
| +10% | +$15.3K | ﹤0.01% | 1933 |
|
|
2022
Q1 | $192K | Sell |
5,506
-324
| -6% | -$11.3K | ﹤0.01% | 1752 |
|
|
2021
Q4 | $189K | Sell |
5,830
-6,263
| -52% | -$203K | ﹤0.01% | 1815 |
|
|
2021
Q3 | $357K | Buy |
12,093
+10,539
| +678% | +$311K | 0.01% | 1241 |
|
|
2021
Q2 | $40K | Buy |
1,554
+945
| +155% | +$24.3K | ﹤0.01% | 3219 |
|
|
2021
Q1 | $8K | Buy |
609
+509
| +509% | +$6.69K | ﹤0.01% | 4491 |
|
|
2020
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 4934 |
|